Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
5.82
Jun. 05, 2023 15:57:24- Change -0.24 (-3.9604%)
- Volume 14,794
- Today's Open 6.02
- Previous Close 6.06
- Today's High 6.1315
- Today's Low 5.8
- 52 Week High 9.9
- 52 Week Low 1.998